Clinical trial
A Safety and Effectiveness Study of Acetaminophen Extended Release (3900 mg/Day)…
NCT00261560 · Johnson & Johnson Consumer and Personal Products Worldwide, Industry · Completed
Key facts
| NCT number | NCT00261560 |
|---|---|
| Title | A Safety and Effectiveness Study of Acetaminophen Extended Release (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Pain Associated With Ankle Sprains. |
| Official title | A Randomized, Double-Blind, Parallel-Group Study Comparing the Safety and Effectiveness of Acetaminophen Extended Release (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Ankle Sprains. |
| Lead sponsor | Johnson & Johnson Consumer and Personal Products Worldwide, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sprains and Strains, Pain |
| Intervention type | Drug |
| Interventions | acetaminophen |
| Enrollment | 260 |
| Completion | Feb 1, 2004 |
| First posted | Dec 5, 2005 |
| Last update posted | Jun 29, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: